Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Medtronic Dividend Announcement
• Medtronic announced a quarterly dividend of $0.70 per ordinary share which will be made payable on 2025-01-10. Ex dividend date: 2024-12-27
• Medtronic annual dividend for 2024 was $2.79
• Medtronic annual dividend for 2023 was $2.75
• Medtronic's trailing twelve-month (TTM) dividend yield is 3.37%
• Medtronic's payout ratio for the trailing twelve months (TTM) is 84.54%
• Medtronic's dividend growth over the last five years (2018-2023) was 13.50% year
• Medtronic's dividend growth over the last ten years (2013-2023) was 9.60% year
Medtronic Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-27 | $0.70 | quarterly | 2025-01-10 |
2024-09-27 | $0.70 | quarterly | 2024-10-11 |
2024-06-28 | $0.70 | quarterly | 2024-07-12 |
2024-03-21 | $0.69 | quarterly | 2024-04-12 |
2023-12-19 | $0.69 | quarterly | 2024-01-12 |
2023-09-21 | $0.69 | quarterly | 2023-10-13 |
2023-06-22 | $0.69 | quarterly | 2023-07-14 |
2023-03-23 | $0.68 | quarterly | 2023-04-14 |
2022-12-20 | $0.68 | quarterly | 2023-01-13 |
2022-09-22 | $0.68 | quarterly | 2022-10-14 |
2022-06-23 | $0.68 | quarterly | 2022-07-15 |
2022-03-24 | $0.63 | quarterly | 2022-04-22 |
2021-12-21 | $0.63 | quarterly | 2022-01-14 |
2021-09-23 | $0.63 | quarterly | 2021-10-15 |
2021-06-24 | $0.63 | quarterly | 2021-07-16 |
2021-03-25 | $0.58 | quarterly | 2021-04-16 |
2020-12-21 | $0.58 | quarterly | 2021-01-15 |
2020-09-24 | $0.58 | quarterly | 2020-10-16 |
2020-06-25 | $0.58 | quarterly | 2020-07-17 |
2020-03-26 | $0.54 | quarterly | 2020-04-17 |
2019-12-26 | $0.54 | quarterly | 2020-01-17 |
2019-09-26 | $0.54 | quarterly | 2019-10-18 |
2019-07-05 | $0.54 | quarterly | 2019-07-25 |
2019-03-21 | $0.50 | quarterly | 2019-04-12 |
2018-12-27 | $0.50 | quarterly | 2019-01-18 |
2018-07-05 | $0.50 | quarterly | 2018-07-25 |
2018-03-22 | $0.46 | quarterly | 2018-04-13 |
2017-12-28 | $0.46 | quarterly | 2018-01-19 |
2017-09-28 | $0.46 | quarterly | 2017-10-20 |
2017-07-05 | $0.46 | quarterly | 2017-07-26 |
2017-03-22 | $0.43 | quarterly | 2017-04-13 |
2016-12-21 | $0.43 | quarterly | 2017-01-13 |
2016-09-27 | $0.43 | quarterly | 2016-10-21 |
2016-07-06 | $0.43 | quarterly | 2016-07-27 |
2016-03-22 | $0.38 | quarterly | 2016-04-15 |
2015-12-22 | $0.38 | quarterly | 2016-01-15 |
2015-09-23 | $0.38 | quarterly | 2015-10-16 |
2015-06-25 | $0.38 | quarterly | 2015-07-17 |
2015-03-26 | $0.30 | quarterly | 2015-04-17 |
2014-12-30 | $0.30 | quarterly | 2015-01-16 |
2014-10-01 | $0.30 | quarterly | 2014-10-24 |
2014-07-01 | $0.30 | quarterly | 2014-07-25 |
2014-04-02 | $0.28 | quarterly | 2014-04-25 |
2013-12-31 | $0.28 | quarterly | 2014-01-24 |
2013-10-02 | $0.28 | quarterly | 2013-10-25 |
2013-07-02 | $0.28 | quarterly | 2013-07-26 |
2013-04-03 | $0.26 | quarterly | 2013-04-26 |
Medtronic Dividend per year
Medtronic Dividend growth
Medtronic Dividend Yield
Medtronic current trailing twelve-month (TTM) dividend yield is 3.37%. Interested in purchasing Medtronic stock? Use our calculator to estimate your expected dividend yield:
Medtronic Financial Ratios
Medtronic Dividend FAQ
Other factors to consider when evaluating Medtronic as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Medtronic stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Medtronic's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Medtronic publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Medtronic distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Medtronic are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Medtronic sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Medtronic distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Medtronic declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Medtronic's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Medtronic's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.